The comparative risk of serious infections among rheumatoid arthritis patients starting or switching...
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Scope and Contents
Contents
Background It is unclear whether anti-tumour necrosis factor alpha and biological agents with different mechanisms of action have similar safety. This study evaluated the incidence of hospitalised infections among rheumatoid arthritis (RA) patients starting or switching various biological agents. Methods Using a database from a large US healthcare...
Alternative Titles
Full title
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3128235
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3128235
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/ard.2010.146365
